How much funding has Sionna Therapeutics raised?

Sionna Therapeutics has raised $182.0M in total funding, most recently a Series C round.

When was Sionna Therapeutics founded?

Sionna Therapeutics was founded in 2019.

Where is Sionna Therapeutics headquartered?

Sionna Therapeutics is headquartered in Waltham, Massachusetts, United States.

What industry is Sionna Therapeutics in?

Sionna Therapeutics operates in Biotech, Healthcare.

How many employees does Sionna Therapeutics have?

Sionna Therapeutics has 11-50 employees.

Sionna Therapeutics

IPO

Public · Waltham, United States · Founded 2019 · $182.0M raised

Biotech

Healthcare

Headquarters: Waltham, Massachusetts
Employees: 11–50
Founded: 2019
Business Model: B2B
Website: sionnatx.com

Total Funding: $182.0M
Last Round: $182.0M Series CMar 2024
Rounds: 1
Type: Public

About

Sionna Therapeutics is a clinical-stage biopharmaceutical company founded in 2019 to develop novel treatments for cystic fibrosis by targeting NBD1, the site of the most common CF-causing mutation. The company is advancing a portfolio of NBD1 stabilizers and complementary CFTR modulators designed to work synergistically to normalize CFTR function beyond current approved therapies.

Summary

Sionna Therapeutics is a Biotech company based in Waltham, United States, founded in 2019. It has raised $182.0M in total across 1 round, most recently a $182.0M Series C round in Mar 2024.

LinkedIn X (Twitter)